Get the App

Back Stocks profile

Stock analysis tool for investors

Aristo Bio-Tech and Lifescience Ltd.

NSE: ARISTO | BSE:

₹81.00 -2.05 (-2.47%) 1D

Chemicals & Petrochemicals

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

81.00

Today’s High

82.00

52W low

53.10

52W High

101.90

Open Price

82.00

Prev. Close

62.5000

Volume

6400.00

Value

518400.00

Fundamentals

Market Cap Cr

55.10

Price to Earnings

0.00

Price to Book Value

1.80

Dividend Yield

0.30

PE to Growth

0.00

Op Revenue TTM Cr

0.00

Net Profit TTM Cr

0.00

Cash From Operating Activity Cr

-2.78

Return on Equity %

11.81

EMA & SMA

Bullish Moving Averages

11

Bearish Moving Averages

5

5Day EMA

84.5

10Day EMA

82.9

12Day EMA

82.1

20Day EMA

79.6

26Day EMA

78.5

50Day EMA

76.8

100Day EMA

75.7

200Day EMA

72.9

5Day SMA

85

10Day SMA

83.6

20Day SMA

77.2

30Day SMA

73.5

50Day SMA

76.7

100Day SMA

74.4

150Day SMA

75.8

200Day SMA

74.8

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

26 Apr, 2024

100

Week

72.5

Month

66.6

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

83.75

PIVOT

First Resistance

84.45

Second Resistance

85.85

Third Resistance

86.55

First Support

82.35

Second Support

81.65

Third Support

80.25

Relative Strength Index

55.75

Money Flow Index

84.46

MACD

3.58

MACD Signal

2.68

Average True Range

5.08

Average Directional Index

25.89

Rate of Change (21)

18.81

Rate of Change (125)

-2.24

Commodity Channel Index

59.6

Williams %R

-47.8

BETA

1 Month

0.91

3 Month

-1.01

1 Year

-0.2

3 Year

PRICE CHANGE ANALYSIS

↓ -1.04%

1 Week

Low

High

81

89.6

↑ 29.7%

1 Month

Low

High

66.05

95

↑ 12.11%

3 Months

Low

High

53.1

98.7

↓ -3.51%

6 Months

Low

High

53.1

98.7

↑ 36.36%

1 Year

Low

High

53.1

101.9

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 218.18 166.03 167.23 201.24 201.77
Operating Expenses Annual Cr 209.15 160.53 162.87 196.72 194.85
Operating Profit Annual 8.70 5.46 4.34 3.41 5.02
Operating Profit Margin Annual % 3.99 3.29 2.60 1.69 2.49
Total Expenses Annual Cr 213.44 163.99 165.73 199.84 197.60
EBIDT Annual Cr 9.03 5.50 4.36 4.52 6.93
EBIDT Annual margin % 4.14 3.31 2.60 2.24 3.43
Depreciation 1.54 1.10 0.75 0.52 0.51
PAT Before ExtraOrdinary Items Annual Cr 3.56 1.46 1.08 0.97 2.94
Net Profit Annual 3.56 1.46 1.08 0.97 2.94
Basic EPS Annual 6.72 2.93 2.15 0.19 5.88
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 30.16 14.84 13.38 12.37 11.40
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 10.19 11.20 12.06 10.69 8.43
Total Current Liabilities Annual Cr 59.49 50.96 55.97 64.85 70.86
Total Capital Plus Liabilities Annual Cr 99.83 77.00 81.42 87.92 90.70
Fixed Assets Annual 16.72 14.46 12.31 11.08 4.17
Total Non Current Assets Annual 16.72 14.46 12.31 11.22 10.47
Total Current Assets Annual 83.10 62.54 69.10 76.70 80.23
Total Assets Annual 99.83 77.00 81.42 87.92 90.70
Contingent Liabilities plus Commitments Annual Cr 0.72 0.65 0.06 0.00 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual -2.78 6.82 2.28 2.62 7.12
Cash from Investing Activity Annual -3.75 -3.19 -1.98 -2.19 -2.75
Cash from Financing Annual Activity 7.97 -3.33 -0.72 -0.34 -4.54
Net Cash Flow Annual 1.44 0.30 -0.41 0.09 -0.16
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 44.30 29.71 26.79 24.77 22.83
ROE Annual % 11.81 9.84 8.03 7.81 25.73
ROCE Annual % 18.57 16.91 14.17 17.32 32.35
Total Debt to Total Equity Annual 0.75 1.72 1.66 1.48 1.27
EBDIT Annual Margin % 4.14 3.31 2.60 2.25 3.46
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Graph
Total Revenue Annual
Operating Expenses Annual Cr
Operating Profit Annual
Operating Profit Margin Annual %
Total Expenses Annual Cr
EBIDT Annual Cr
EBIDT Annual margin %
Depreciation
PAT Before ExtraOrdinary Items Annual Cr
Net Profit Annual
Basic EPS Annual
Indicator Graph
Total ShareHolders Funds Annual
Minority Interest Liability Annual Cr
Total Non Current Liabilities Annual Cr
Total Current Liabilities Annual Cr
Total Capital Plus Liabilities Annual Cr
Fixed Assets Annual
Total Non Current Assets Annual
Total Current Assets Annual
Total Assets Annual
Contingent Liabilities plus Commitments Annual Cr
Indicator Graph
Cash from Operating Activity Annual
Cash from Investing Activity Annual
Cash from Financing Annual Activity
Net Cash Flow Annual
Indicator Graph
Book Value Per Share Annual
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual
EBDIT Annual Margin %
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Narendra Singh Barhat 33.49 75288074 0 35.09
Ketankumar Harkantbhai Joshi 10.58 75288075 0 41.67
Kusum Barhat 9.18 75288076 0 48
Himanshu Barhat 7.56 75288077 0 0
Neeta K Joshi 7.05 75288078 0 0
N S Barhat HUF 3.67 75288079 0 0
Richa N Barhat 1.84 75288080 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
HUF 0.99 75288087
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 15, 2023 0.25 FINAL Sep 15, 2023 Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Nov 07, 2023 Quarterly Results -
May 27, 2023 Audited Results & Dividend -
Ex-Date Bonus Ratio Record Date

FAQs

The latest market price of Aristo Bio-Tech and Lifescience Ltd. on NSE was Rs. 81.00 as of today.

The opening share price of Aristo Bio-Tech and Lifescience Ltd. was Rs. 82.00 as of today.

The 52-week high share price of Aristo Bio-Tech and Lifescience Ltd. was Rs. 101.90.

The 52 week low share price of Aristo Bio-Tech and Lifescience Ltd. was Rs. 53.10.

Aristo Bio-Tech and Lifescience Ltd. has a market cap of Rs. 55.10 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aristo Bio-Tech and Lifescience Ltd. is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Aristo Bio-Tech and Lifescience Ltd. in the last FY was Rs.  0.00 crore. Please refer to the Financials section for further details.

The Net Profit for Aristo Bio-Tech and Lifescience Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aristo Bio-Tech and Lifescience Ltd. was on 2023-09-15 for Rs. 0.25 per share. According to today’s share price, the dividend yield of Aristo Bio-Tech and Lifescience Ltd. stands at 0.30. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aristo Bio-Tech and Lifescience Ltd..

Close

Let's Open Free Demat Account